Aortic regurgitation in 2026

Sponsored by JenaValve Technology
TAVI
Symposium
JenaValve Technology
Room 251

Watch this session if you want

  • To understand how to diagnosis and optimie the treatment of aortic regurgitation (AR) and help improve patient care of this undertreated disease
  • To learn about and observe cases featuring the JenaValve Trilogy System, the only CE mark-approved device for treating both severe aortic regurgitation and aortic stenosis
  • To learn about the future of TAVI for aortic regurgitation and what may come next

Suggested videos